Chondroitin 4-O-sulfation regulates hippocampal perineuronal nets and social memory

Glycan alterations are associated with aging, neuropsychiatric, and neurodegenerative diseases, although the contributions of specific glycan structures to emotion and cognitive functions remain largely unknown. Here, we used a combination of chemistry and neurobiology to show that 4 -O-sulfated chondroitin sulfate (CS) polysaccharides are critical regulators of perineuronal nets (PNNs) and synapse development in the mouse hippocampus, thereby affecting anxiety and cognitive abilities such as social memory. Brain-specific deletion of CS 4-O-sulfation in mice increased PNN densities in the area CA2 (cornu ammonis 2), leading to imbalanced excitatory-to-inhibitory synaptic ratios, reduced CREB activation, elevated anxiety, and social memory dysfunction. The impairments in PNN densities, CREB activity, and social memory were recapitulated by selective ablation of CS 4-O-sulfation in the CA2 region during adulthood. Notably, enzymatic pruning of the excess PNNs reduced anxiety levels and restored social memory, while chemical manipulation of CS 4-O-sulfation levels reversibly modulated PNN densities surrounding hippocampal neurons and the balance of excitatory and inhibitory synapses. These findings reveal key roles for CS 4-O-sulfation in adult brain plasticity, social memory, and anxiety regulation, and they suggest that targeting CS 4-O-sulfation may represent a strategy to address neuropsychiatric and neurodegenerative diseases associated with social cognitive dysfunction.

Automated summary

This study demonstrates that 4-O-sulfated chondroitin sulfate polysaccharides play a critical role in the regulation of perineuronal nets (PNNs) and synapse development in the mouse hippocampus, impacting anxiety and cognitive functions such as social memory. Alterations in CS 4-O-sulfation lead to imbalanced synaptic ratios, elevated anxiety levels, and social memory dysfunction. Modulating CS 4-O-sulfation levels reversibly affects PNN densities and the balance of excitatory and inhibitory synapses. Targeting CS 4-O-sulfation may offer therapeutic potential for addressing neuropsychiatric and neurodegenerative diseases associated with social cognitive dysfunction.